Xavier C. Badoux

Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study

William G. Wierda, John N. Allan, Tanya Siddiqi et al. · Journal of Clinical Oncology · 2021 · 217 citations · Full text

Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial

Jeffrey A. Jones, Tadeusz Robak, Jennifer R. Brown et al. · The Lancet Haematology · 2017 · 198 citations

Hematological Malignancy, Lymphoid Neoplasia, Chronic Lymphocytic Leukaemia +10

Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL

Xavier C. Badoux, Michael J. Keating, Xuemei Wang et al. · Blood · 2011 · 187 citations · Full text

Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia

Xavier C. Badoux, Michael J. Keating, Sijin Wen et al. · Blood · 2011 · 164 citations · Full text

Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Xavier C. Badoux, Michael J. Keating, Sijin Wen et al. · Journal of Clinical Oncology · 2012 · 153 citations · Full text